Arecor is a startup based in the United Kingdom, most recent round Series B, 2 tracked investors.
Arecor is a company headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Arecor is a clinical-stage biopharmaceutical company developing superior therapeutics that reduce treatment burden and improve outcomes for people living with diabetes, obesity, and other cardiometabolic diseases, utilizing its proprietary Arestat® technology platform for innovative drug formulation and delivery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.